Medical Weight Loss for Hazleton, Pennsylvania Residents

Hazleton, Pennsylvania residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Hazleton through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Start this week from Hazleton: book a video visit, complete your intake, and if you are a fit, your compounded medication ships to your Pennsylvania door. No travel to California required. Doctor review just $119 (medication separate).

Why Hazleton Residents Choose New Hope Weight Loss

A lot of clinics talk about supervision in the abstract. We can name the person doing it. Dr. Anjmun Sharma, MD oversees every Hazleton case personally, which means your dose, your check-ins, and your safety calls are decisions a single physician owns from start to finish. Compounded GLP-1 medication deserves that kind of continuity, and we would rather give you one accountable doctor than a queue of interchangeable ones.

Medical weight loss for Hazleton is handled end-to-end online: intake, the $119 physician review with Dr. Sharma, dose titration, and follow-ups, all by secure video, with no drive and no pharmacy line.

Telehealth is what lets us care for Hazleton, Pennsylvania from a single office in Costa Mesa, so you get Dr. Sharma's full attention without rearranging your day around an appointment across town. We care for patients throughout downtown Hazleton and the greater Luzerne County area of northeastern Pennsylvania. There is no distance surcharge for living outside Costa Mesa, and we accept HSA, FSA, Klarna, and Affirm to make starting easier across Pennsylvania.

Telehealth lets you skip the commute entirely, so the time you would have spent driving across Hazleton goes straight into starting your program. For patients across Hazleton, compounded semaglutide starts at $166 per month, with a 90-day program available for $499, and the medication cost is kept separate from the $119 physician review. Pennsylvania is one of the most populous states in the country, and New Hope Weight Loss serves patients across it by secure telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Two GLP-1 paths, one plan built around you

The 90-Day Metabolic Reset uses semaglutide, the same active ingredient in Wegovy and Ozempic. From $166 a month, or $499 for the full 90 days, it pairs medication with monthly check-ins. Branded-drug trials showed average loss of about 15 to 17 percent. Compounded semaglutide is not FDA-approved and not brand-identical, and results vary from person to person.

Want a stronger option? Ask about tirzepatide

From $233 a month, tirzepatide combines GLP-1 and GIP action. Trial participants on qualifying doses saw up to 22.5 percent body-weight loss, a top-dose number rather than the average. It carries the same active ingredient as Mounjaro and Zepbound.

Your $119 physician review comes first. Medication is billed separately. HSA, FSA, Klarna, and Affirm are all welcome for Hazleton patients.

How Telehealth Works for Hazleton

Here is how the whole thing works, start to finish, for anyone in Hazleton.

First, you fill out an intake and quiz about your weight history and current health. Next, Dr. Sharma looks it over and meets you by secure video, almost always within 48 hours, to see whether compounded semaglutide or tirzepatide fits your situation. Then, if she prescribes, a state-licensed 503(a) pharmacy ships the medication to your Hazleton address in cold-pack packaging built to protect it on the road. After that, every follow-up is a video visit, so the care continues no matter where you are in .

Frequently Asked Questions, Hazleton

Is New Hope Weight Loss available to Hazleton without a local branch?

Yes, even though we have no branch in Hazleton. Our one physical clinic is in Costa Mesa, California, and we reach Hazleton, Pennsylvania through telehealth. A secure video consult with Dr. Anjmun Sharma is where your medical history is reviewed and your fit for a compounded GLP-1 plan is confirmed.

From Hazleton, can I avoid traveling for appointments?

You can skip travel entirely. The program is built around telehealth, so Hazleton patients meet the doctor online, complete intake digitally, and stay connected by message. If approved, medication ships to your Hazleton home in cold-pack packaging that maintains a safe temperature on the way.

What will Hazleton patients spend on the program?

Expect $119 for the physician visit. Compounded semaglutide is offered from $166 per month or $499 for 90 days, and tirzepatide from $233 per month. The medication is billed separately. HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge for Hazleton residents at all.

What areas of Hazleton do you serve?

We serve patients from across Hazleton by telehealth, including downtown Hazleton and the greater Luzerne County area of northeastern Pennsylvania.

What does treatment cost for Hazleton patients?

The same flat pricing nationwide: a $119 physician visit, compounded semaglutide from $166/month, and compounded tirzepatide from $233/month, with medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, and there is no distance surcharge for Hazleton.

Hazleton Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Hazleton, Pennsylvania by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.